If the trial is against saline (a true placebo) the chance of success is greater than if it is against a thrombolytic that is FDA approved (TPA) for acute stroke. Intra cranial TPA is given up to 6 hours and for really bad prognosis stroke like a basilar artery thrombosis even up to 12 hrs. If the trial was done against mechanical dissolution like the concentrix device it might be harder to achieve a good result.
Just wondering. I suspect if the drug is going against a placebo the result will likely be good.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.